- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02568189
Utility of Ultrasound Assessment of the Inferior Vena Cava in Patients With Sepsis and Dehydration
Randomized Controlled Trial of Inferior Vena Cava Ultrasonography in the Management and Disposition of Pediatric Patients Undergoing Evaluation for Sepsis and Dehydration
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Ultrasound is a widely accepted and highly useful clinical tool. It carries the additional advantage of being rapid, painless and non-radiating. It has long been used to assess cardiac output and vascular pathologies. More recently emergency and trauma clinicians have been using it to assess hydration status, shock/sepsis states and fluid responsiveness. Using sonography to look at the inferior vena cava gives clinician a rapid view of vascular collapsibility that has been previously demonstrated to correlate with mean arterial pressure (MAP) and central venous pressure (CVP). Previously, Jones et. al. completed an randomized controlled trial (RCT) in adults greater than age 17 evaluating the goal directed utility of early versus delayed inferior vena cava sonography for patients presenting with non traumatic hypotension to the emergency department. This study found improved outcomes and more accuracy in diagnostic etiology in those undergoing immediate IVC imaging. The study conducts a randomized controlled trial of IVC Ultrasonography in pediatric patients 0-21 year of age.
Patients admitted to the Emergency Department and triggering triage STOP SEPSIS ALERT (based on triage vital signs and chief complaint), vomiting requiring zofran or diarrhea with concern for dehydration/hypovolemia, the treating physician believes would benefit from intravenous fluids, will be eligible for inclusion into this study. The "treating physician" refers to one of the Pediatric Emergency Medicine attendings or fellows, listed as co-investigators. Only if and when a patient or parent expresses interest in participating in the study, the attending or fellow caring for the patient will determine if the patient is eligible. If the patient is eligible, and has no criteria that would exclude them from the study, written informed consent will be obtained from the guardian and assent will be obtained in children > 7 years old. The patient will be enrolled in the study and randomized to either the immediate ultrasonography group (Ultrasound (US) of the Inferior Vena Cava (IVC) first before the clinician fully assesses the patient and places rehydration orders) or the control group (US at 15 minutes into the assessment and management of the patient). The goal will be to assess how the use of ultrasound impacts clinical management and outcomes in patients presenting to the pediatric emergency department with sepsis and dehydration.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10029
- Mount Sinai Hospital Department of Emergency Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Trigger triage STOP SEPSIS ALERT (based on triage vital signs and chief complaint)
- Present with vomiting requiring Zofran
- Present with diarrhea with concern for dehydration/hypovolemia
Exclusion Criteria:
- Unstable patients with life-threatening injuries who require ongoing resuscitation
- Patient undergoing traumatic resuscitation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Sepsis 1
Sepsis patients receiving SonoSite Maxx Series Ultrasound System ultrasound prior to clinical orders including medication and fluid orders being placed by the treating physician
|
Ultrasound imaging is a non-radiating, non invasive modality to assess many areas of the body including vascular fluid status.
By placing the probe on the abdomen and looking at the inferior vena cava the clinician can assess a patient's degree of dehydration.
We are evaluating the utility of this diagnostic intervention within the clinical management of patients in the pediatric emergency department.
|
|
Active Comparator: Sepsis 2
Sepsis patients having SonoSite Maxx Series Ultrasound System ultrasound performed after clinical orders have been placed by the treating physician
|
Ultrasound imaging is a non-radiating, non invasive modality to assess many areas of the body including vascular fluid status.
By placing the probe on the abdomen and looking at the inferior vena cava the clinician can assess a patient's degree of dehydration.
We are evaluating the utility of this diagnostic intervention within the clinical management of patients in the pediatric emergency department.
|
|
Experimental: Gastroenteritis 1
Patients with gastroenteritis receiving SonoSite Maxx Series Ultrasound System ultrasound prior to having orders placed by treating physician
|
Ultrasound imaging is a non-radiating, non invasive modality to assess many areas of the body including vascular fluid status.
By placing the probe on the abdomen and looking at the inferior vena cava the clinician can assess a patient's degree of dehydration.
We are evaluating the utility of this diagnostic intervention within the clinical management of patients in the pediatric emergency department.
|
|
Active Comparator: Gastroenteritis 2
Patients with gastroenteritis having SonoSite Maxx Series Ultrasound System ultrasound after initial clinical orders are placed by treating physician
|
Ultrasound imaging is a non-radiating, non invasive modality to assess many areas of the body including vascular fluid status.
By placing the probe on the abdomen and looking at the inferior vena cava the clinician can assess a patient's degree of dehydration.
We are evaluating the utility of this diagnostic intervention within the clinical management of patients in the pediatric emergency department.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Type of Re-hydration
Time Frame: Day 1
|
Type of re-hydration: oral vs. intravenous at the time of disposition from the Emergency Department (ED)
|
Day 1
|
|
Vascular Access Point
Time Frame: Day 1
|
For sepsis arm, Secured second vascular access point- type (Interosseous (IO), second Intravenous (IV), central venous (CV) access) within 15 min of physician evaluation
|
Day 1
|
|
Antibiotic Use
Time Frame: 60 minutes
|
For sepsis arm, antibiotic given within 60 min
|
60 minutes
|
|
Normal Saline Bolus
Time Frame: 60 minutes
|
For sepsis arm, 60 ml/kg Normal Saline bolus administered within 60 minutes
|
60 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Disposition Status
Time Frame: Day 1
|
Pediatric Intensive Care Unit (PICU), Floor, Discharge
|
Day 1
|
|
Length of ED Stay (From Sepsis Alert to Admission/Discharge Order Entry)
Time Frame: Time between emergency department registration and disposition (admit, transfer or discharge)
|
Time between emergency department registration and disposition (admit, transfer or discharge)
|
|
|
Return ED Visit for Same Illness Within 48 Hours
Time Frame: 48 hours
|
At greater than 48 hours post emergency department disposition
|
48 hours
|
|
Survival to Hospital Discharge
Time Frame: 30 days
|
For sepsis arm, at time of emergency department or hospital discharge
|
30 days
|
|
30 Day Mortality
Time Frame: 30 days
|
Assessed any time after 30 days from emergency department registration date.
|
30 days
|
|
Left Ventricular Function
Time Frame: Day 1
|
For sepsis arm, during emergency department visit
|
Day 1
|
|
Source of Sepsis
Time Frame: Day 1
|
For sepsis arm, during emergency department or hospital visit
|
Day 1
|
Collaborators and Investigators
Investigators
- Principal Investigator: James Tsung, MD, Icahn School of Medicine at Mount Sinai
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GCO 15-1599
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of California, San FranciscoNational Cancer Institute (NCI)RecruitingSepsis | Sepsis, Severe | Sepsis and Septic Shock | Sepsis at Intensive Care Unit | Sepsis, Septic Shock | Sepsis, Severe Sepsis and Septic Shock | Sepsis With Multiple Organ Dysfunction (MOD) | Sepsis With Acute Organ DysfunctionUnited States
-
Assiut UniversityNot yet recruitingSepsis Induced Myocardial Dysfunction | Sepsis Induced CardiomyopathyEgypt
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityEnrolling by invitationSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
-
Rennes University HospitalUnknownSevere Sepsis or Septic Shock
Clinical Trials on SonoSite Maxx Series Ultrasound System
-
Assiut UniversityNot yet recruitingAirway Complication of AnesthesiaEgypt
-
Manuel C. VallejoCompleted
-
Ascension Genesys HospitalCompletedMass CasualtyUnited States
-
VA Connecticut Healthcare SystemTerminatedOsteoarthritisUnited States
-
Edward Via Virginia College of Osteopathic MedicineVirginia Polytechnic Institute and State UniversityCompletedHepatitis | Cholecystitis | Ascites | Pancreatitis | Urolithiasis | Cholangitis | Portal Hypertension | Cholelithiasis | Hydronephrosis | Abdominal Aortic Aneurysm | Abnormal Uterine Bleeding | Ovarian Torsion | Blunt Abdominal Trauma | Ovarian MassDominican Republic
-
University of Alabama at BirminghamWithdrawn
-
University of LouisvilleCompletedUltrasound Measurements | Normative ValuesUnited States
-
The Hawkins FoundationCompleted
-
Mayo ClinicWithdrawnOsteoarthritis | Inflammatory ArthritisUnited States
-
Yale UniversityCompletedUltrasonographyUnited States